Mina Stajčić

Mina Stajčić

Auto-generated profile, based on publicly available information

Mina Stajčić


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Medicinska istrazivanja
Verified
Journal Article
Open access
PDF file
JMJovana Kusic Milicevic
Jovana Kusic Milicevic
MKMarija Karapandžić
Marija Karapandžić
MSMina Stajčić
Mina Stajčić
JDJelena Dodić
Jelena Dodić
MAMarija Anđelković Apostolović
Marija Anđelković Apostolović
ĐOĐorđe
Đorđe
Introduction: During the COVID-19 pandemic, receiving hemodialysis was recognized as a predictor of poor survival. This study evaluated in-hospital and late survival in patients treated with hemodialysis during COVID-19 hospitalization. Methods: This single-center retrospective study included 176 patients requiring hemodialysis during COVID-19 hospitalization. Patients were divided into three groups: acute kidney injury (AKI), acute-on-chronic kidney disease (aCKD), and chronic hemodialysis (HD). Data was collected from patients' electronic records. Results: The majority (73.3%) of the study population were chronic hemodialysis patients. The overall in-hospital mortality was high (35.8%), and differed significantly among groups: 82.1%, 57.9% and 22.5% in the AKI, aCKD, and HD patients, respectively (p<0.001). After 12 months, death occurred in almost 30% of the reached patients, of whom the majority were from the chronic hemodialysis group. Conclusion: Dialysis-dependent patients experience high mortality during COVID-19, especially those who develop AKI and aCKD. Chronic hemodialysis patients are exposed to better in-hospital survival; however, their one-year mortality remains significant.